Medicine
Jardiance 10 mg tablet
Jardiance 10 mg tablet is a prescription medicine containing Empagliflozin for oral use, marketed by Boehringer Ingelheim Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Empagliflozin
- Brand
- Jardiance
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 30 blister pack, 90 tablets and 6 more
- Marketing authorisation holder
- Boehringer Ingelheim Pharmaceuticals
- Manufacturers
- Boehringer Ingelheim PharmaceuticalsA-S Medication SolutionsAphena Pharma Solutions - TennesseeCardinal Health
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BK03 Empagliflozin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 August 2014
- Identifiers
- RxCUI 1545658, 1545664, 1545666 +1DailyMed set ID faf3dd6a-9cd0-39c2-0d2e-232cb3f67565, 1782b947-4a72-4feb-a488-1469d9af82bd, 942a82a4-cbbd-4e44-9965-8d03f767912b +2NDC 0597-0152, 50090-6452, 50090-4492 +2Application NDA204629
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 0597-0152-30 | Boehringer Ingelheim Pharmaceuticals | 1 August 2014 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0597-0152-37 | Boehringer Ingelheim Pharmaceuticals | 1 August 2014 |
| 90 tablet, film coated in 1 bottle | 0597-0152-90 | Boehringer Ingelheim Pharmaceuticals | 1 August 2014 |
| 90 tablet, film coated in 1 bottle | 50090-4492-0 | A-S Medication Solutions | 29 August 2019 |
| 30 tablet, film coated in 1 bottle | 50090-4492-1 | A-S Medication Solutions | 18 July 2023 |
| 90 tablet, film coated in 1 bottle | 50090-6452-0 | A-S Medication Solutions | 27 April 2023 |
| 9000 tablet, film coated in 1 bottle | 71610-900-09 | Aphena Pharma Solutions - Tennessee | 17 April 2025 |
| 4500 tablet, film coated in 1 bottle | 71610-900-97 | Aphena Pharma Solutions - Tennessee | 17 June 2026 |
| 720 tablet, film coated in 1 bottle, plastic | 55154-0411-8 | Cardinal Health | 1 August 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Empagliflozin
Clinical summary
Empagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. It is available as tablets for oral use. MedsAcross supplies Empagliflozin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EmpagliflozinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Jardiance prescribing information (Boehringer Ingelheim Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Jardiance: European public assessment report (EPAR) · European Medicines Agency
Need Jardiance 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.